TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2

Zhang, Ling; Gao, Yingzhen; Zhang, Xiaojuan; Guo, Min; Yang, Jie; Cui, Heyang; Kong, Pengzhou; Niu, Xia; Bi, Yanghui; Xu, Jing; Yan, Ting; Ma, Yanchun; Yang, Jian; Qian, Yu; Wang, Fang; Li, Hongyi; Liu, Feng; Cheng, Xiaolong; Cui, Yongping

doi:10.7150/thno.48225



Nanotheranostics 2024; 8(3): 380-400. [Abstract] [Full text] [PDF]

Nanotheranostics 2024; 8(3): 344-379. [Abstract] [Full text] [PDF] [PubMed] [PMC]

Nanotheranostics

International Journal of Biological Sciences

International Journal of Medical Sciences

Journal of Cancer

Global reach, higher impact

Full Text | PDF

Theranostics 2020; 10(24):11339-11358. doi:10.7150/thno.48225 This issue Cite

Research Paper

TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2

Ling Zhang^1,2#, Yingzhen Gao^1#, Xiaojuan Zhang^1#, Min Guo^1#, Jie Yang^3#, Heyang Cui², Pengzhou Kong¹, Xia Niu¹, Yanghui Bi¹, Jing Xu¹, Ting Yan¹, Yanchun Ma¹, Jian Yang¹, Yu Qian¹, Fang Wang¹, Hongyi Li¹, Feng Liu⁴, Xiaolong Cheng^1✉, Yongping Cui^1,2✉

1. Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
2. Department of Oncology (Radiation Oncology), Cancer Institute, Peking University Shenzhen Hospital, Shenzhen Peking University-the Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen 518035, P. R. China.
3. Department of Gastroenterology, The Second Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
4. Department of Forensic, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
#These authors contributed equally to this work.

✉ Corresponding authors: Yongping Cui, Ph.D., Professor. Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China. Telephone: 8 More

Citation:

Zhang L, Gao Y, Zhang X, Guo M, Yang J, Cui H, Kong P, Niu X, Bi Y, Xu J, Yan T, Ma Y, Yang J, Qian Y, Wang F, Li H, Liu F, Cheng X, Cui Y. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics 2020; 10(24):11339-11358. doi:10.7150/thno.48225. https://www.thno.org/v10p11339.htm

Other styles

Abstract

Background: TSTA3 gene encodes an enzyme responsible for synthesis of GDP-L-fucose as the only donor in fucosylation. This study was designed to explore clinical value, function and underlying mechanism of TSTA3 in the development of esophageal squamous cell carcinoma (ESCC).

Methods: Whole genomic sequencing data from 663 ESCC patients and RNA sequencing data from 155 ESCC patients were used to analyze the copy number variation and mRNA expression of TSTA3 respectively. Immunohistochemistry based or not based on the tissue microarrays was used to detect its protein expression. Transwell assay and in vivo metastasis assay were used to study the effect of TSTA3 on invasion and metastasis of ESCC. Immunofluorescence was used to analyze fucosylation level. N-glycoproteomics and proteomics analysis, Lens Culinaris Agglutinin (LCA) and Ulex Europaeus Agglutinin I (UEA-I) affinity chromatography, immunoprecipitation, glycosyltransferase activity kit and rescue assay were used to explore the mechanism of TSTA3.

Results: TSTA3 was frequently amplified and overexpressed in ESCC. TSTA3 amplification and protein overexpression were significantly associated with malignant progression and poor prognosis of ESCC patients. TSTA3 knockdown significantly suppressed ESCC cells invasion and tumor dissemination by decreasing fucosylation level. Conversely, exogenous overexpression of TSTA3 led to increased invasion and tumor metastasis in vitro and in vivo by increasing fucosylation level. Moreover, core fucosylated LAMP2 and terminal fucosylated ERBB2 might be mediators of TSTA3-induced pro-invasion in ESCC and had a synergistic effect on the process. Peracetylated 2-F-Fuc, a fucosyltransferase activity inhibitor, reduced TSTA3 expression and fucosylation modification of LAMP2 and ERBB2, thereby inhibiting ESCC cell invasion.

Conclusion: Our results indicate that TSTA3 may be a driver of ESCC metastasis through regulating fucosylation of LAMP2 and ERBB2. Fucosylation inhibitor may have prospect to suppress ESCC metastasis by blocking aberrant fucosylation.

Keywords: ESCC, TSTA3, Fucosylation, LAMP2, ERBB2

Citation styles

APA

Zhang, L., Gao, Y., Zhang, X., Guo, M., Yang, J., Cui, H., Kong, P., Niu, X., Bi, Y., Xu, J., Yan, T., Ma, Y., Yang, J., Qian, Y., Wang, F., Li, H., Liu, F., Cheng, X., Cui, Y. (2020). TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics, 10(24), 11339-11358. https://doi.org/10.7150/thno.48225.

ACS

Zhang, L.; Gao, Y.; Zhang, X.; Guo, M.; Yang, J.; Cui, H.; Kong, P.; Niu, X.; Bi, Y.; Xu, J.; Yan, T.; Ma, Y.; Yang, J.; Qian, Y.; Wang, F.; Li, H.; Liu, F.; Cheng, X.; Cui, Y. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics 2020, 10 (24), 11339-11358. DOI: 10.7150/thno.48225.

NLM

CSE

Zhang L, Gao Y, Zhang X, Guo M, Yang J, Cui H, Kong P, Niu X, Bi Y, Xu J, Yan T, Ma Y, Yang J, Qian Y, Wang F, Li H, Liu F, Cheng X, Cui Y. 2020. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics. 10(24):11339-11358.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.